Ericsson Peter, Norlén Per, Bernsand Maria, Alm Per, Höglund Peter, Håkanson Rolf
Department of Pharmacology, Institute of Physiological Sciences, University of Lund, Lund, Sweden.
Pharmacol Toxicol. 2003 Aug;93(2):57-65. doi: 10.1034/j.1600-0773.2003.930201.x.
The ECL cells are endocrine/paracrine cells in the acid-producing part of the stomach. They secrete histamine in response to circulating gastrin. Gastric submucosal microdialysis has been used to study ECL-cell histamine mobilization in awake rats. In the present study we assess the usefulness and limitations of the technique. Microdialysis probes were implanted in the gastric submucosa. Histological analysis of the stomach wall around the probe revealed a moderate, local inflammatory reaction 1-2 days after implantation; the inflammation persisted for at least 10 days. Experiments were conducted 3 days after the implantation. The "true" submucosal histamine concentration was determined by perfusing at different rates (the zero flow method) or with different concentrations of histamine at a constant rate (the no-net-flux method): in fasted rats it was calculated to be 87+/-5 (means+/-S.E.M.) nmol/l and 76+/-9 nmol/l, respectively. The corresponding histamine concentrations in fed rats were 93+/-5 and 102+/-8 nmol/l, respectively. With a perfusion rate of 74 microl/hr the recovery of submucosal histamine was 49%, at 34 microl/hr the recovery increased to 83%. At a perfusion rate below 20 microl/hr the microdialysate histamine concentration was close to the actual concentration in the submucosa. The ECL-cell histamine mobilization was independent of the concentrations of Ca2+ in the perfusion medium (0-3.4 mmol/l Ca2+). In one experiment, histamine mobilization in response to gastrin (10 nmol/kg/hr subcutaneously) was monitored in rats pretreated with prednisolone (60 mg/kg) or indomethacin (15 mg/kg). The two antiinflammatory agents failed to affect the concentration of histamine in the microdialysate either before or during the gastrin challenge, which was in accord with the observation that the inflammatory reaction was modest and that inflammatory cells were relatively few around the probe and in the wall of the probe. In another experiment, rats were given aminoguanidine (10 mg/kg) or metoprine (10 mg/kg) 4 hr before the start of gastrin infusion (5 nmol/kg/hr intravenously). Metoprine (inhibitor of histamine N-methyl transferase) did not affect the microdialysate histamine concentration, while aminoguanidine (inhibitor of diamine oxidase) raised both basal and gastrin-stimulated histamine concentrations. We conclude that microdialysis can be used to monitor changes in the concentration of histamine in the submucosa of the stomach, and that the inflammatory reaction to the probe is moderate and does not affect the submucosal histamine mobilization.
肠嗜铬样(ECL)细胞是胃产酸部位的内分泌/旁分泌细胞。它们在循环胃泌素的刺激下分泌组胺。胃黏膜下微透析已被用于研究清醒大鼠中ECL细胞组胺的释放。在本研究中,我们评估了该技术的实用性和局限性。将微透析探针植入胃黏膜下层。对探针周围胃壁的组织学分析显示,植入后1 - 2天有中度局部炎症反应;炎症持续至少10天。在植入后3天进行实验。通过不同灌注速率(零流量法)或恒定速率下不同组胺浓度(无净流量法)灌注来测定“真实”的黏膜下组胺浓度:在禁食大鼠中,计算得出分别为87±5(均值±标准误)nmol/L和76±9 nmol/L。喂食大鼠中的相应组胺浓度分别为93±5和102±8 nmol/L。灌注速率为74微升/小时时,黏膜下组胺回收率为49%,34微升/小时时回收率增至83%。灌注速率低于20微升/小时时,微透析液中组胺浓度接近黏膜下实际浓度。ECL细胞组胺释放与灌注培养基中Ca2+浓度(0 - 3.4 mmol/L Ca2+)无关。在一项实验中,监测了用泼尼松龙(60 mg/kg)或吲哚美辛(15 mg/kg)预处理的大鼠对胃泌素(10 nmol/kg/小时皮下注射)的组胺释放反应。这两种抗炎药在胃泌素刺激前或刺激期间均未影响微透析液中组胺浓度,这与炎症反应适度且探针周围及探针壁内炎症细胞相对较少的观察结果一致。在另一项实验中,在胃泌素输注(5 nmol/kg/小时静脉注射)开始前4小时给大鼠注射氨基胍(10 mg/kg)或美托普林(10 mg/kg)。美托普林(组胺N - 甲基转移酶抑制剂)未影响微透析液中组胺浓度,而氨基胍(二胺氧化酶抑制剂)升高了基础和胃泌素刺激后的组胺浓度。我们得出结论,微透析可用于监测胃黏膜下组胺浓度的变化,并且对探针的炎症反应适度,不影响黏膜下组胺的释放。